<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26725834</article-id>
<article-id pub-id-type="pmc">4908638</article-id>
<article-id pub-id-type="pii">npp2015371</article-id>
<article-id pub-id-type="doi">10.1038/npp.2015.371</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chemogenetic and Optogenetic Activation of G<italic>α</italic>s Signaling in the Basolateral Amygdala Induces Acute and Social Anxiety-Like States</article-title>
<alt-title alt-title-type="running">Activation of BLA G<italic>α</italic>s signaling is anxiogenic</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Siuda</surname>
<given-names>Edward R</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al-Hasani</surname>
<given-names>Ream</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McCall</surname>
<given-names>Jordan G</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8295-0664</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhatti</surname>
<given-names>Dionnet L</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bruchas</surname>
<given-names>Michael R</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine</institution>, St Louis, Missouri, <country>USA</country></aff>
<aff id="aff2"><label>2</label><institution>Washington University Pain Center, Washington University School of Medicine</institution>, St Louis, Missouri, <country>USA</country></aff>
<aff id="aff3"><label>3</label><institution>Division of Biology and Biomedical Sciences, Washington University School of Medicine</institution>, St Louis, Missouri, <country>USA</country></aff>
<aff id="aff4"><label>4</label><institution>Department of Neuroscience, Washington University School of Medicine</institution>, St Louis, Missouri, <country>USA</country></aff>
<aff id="aff5"><label>5</label><institution>Department of Biomedical Engineering, Washington University in St. Louis</institution>, St Louis, Missouri, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Departments of Anesthesiology and Neuroscience, Washington University School of Medicine</institution>, 660 South Euclid Avenue, Box 8054, St Louis, MO 63110, <country>USA</country>, Tel: +1 314 747 5754, Fax: +1 314 362 8571, E-mail: <email>bruchasm@wustl.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>07</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epreprint">
<day>04</day>
<month>01</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>01</month>
<year>2016</year>
</pub-date>
<volume>41</volume>
<issue>8</issue>
<fpage>2011</fpage>
<lpage>2023</lpage>
<history>
<date date-type="received">
<day>02</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>12</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>12</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 American College of Neuropsychopharmacology</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>American College of Neuropsychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Anxiety disorders are debilitating psychiatric illnesses with detrimental effects on human health. These heightened states of arousal are often in the absence of obvious threatening cues and are difficult to treat owing to a lack of understanding of the neural circuitry and cellular machinery mediating these conditions. Activation of noradrenergic circuitry in the basolateral amygdala is thought to have a role in stress, fear, and anxiety, and the specific cell and receptor types responsible is an active area of investigation. Here we take advantage of two novel cellular approaches to dissect the contributions of G-protein signaling in acute and social anxiety-like states. We used a chemogenetic approach utilizing the G<italic>α</italic>s DREADD (rM3Ds) receptor and show that selective activation of generic G<italic>α</italic>s signaling is sufficient to induce acute and social anxiety-like behavioral states in mice. Second, we use a recently characterized chimeric receptor composed of rhodopsin and the <italic>β</italic><sub>2</sub>-adrenergic receptor (Opto-<italic>β</italic><sub>2</sub>AR) with <italic>in vivo</italic> optogenetic techniques to selectively activate G<italic>α</italic>s <italic>β</italic>-adrenergic signaling exclusively within excitatory neurons of the basolateral amygdala. We found that optogenetic induction of <italic>β</italic>-adrenergic signaling in the basolateral amygdala is sufficient to induce acute and social anxiety-like behavior. These findings support the conclusion that activation of G<italic>α</italic>s signaling in the basolateral amygdala has a role in anxiety. These data also suggest that acute and social anxiety-like states may be mediated through signaling pathways identical to <italic>β</italic>-adrenergic receptors, thus providing support that inhibition of this system may be an effective anxiolytic therapy.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>